K0706
|
|
- CAS号:
- 1388803-90-4
- 英文名:
- Vodobatinib
- 英文别名:
- Vodobatinib;Vodobatinib (K0706);Vodobatinib (SCO-088, SUN-K706;2-Chloro-6-methyl-N'-(4-methyl-3-(quinolin-3-ylethynyl)benzoyl)benzohydrazide;2-Chloro-6-methyl-N'-(4-methyl-3-(quinolin-3-ylethynyl)benzoyl)benzohydrazide;N'-(2-chloro-6-methylbenzoyl)-4-methyl-3-[2-(3-quinolyl)ethynyl]-benzohydrazide;myeloid,Inhibitor,inhibit,Vodobatinib,chronic,K0706,Bcr-Abl,K 0706,Bcr-Abl1,leukemia,TKI;Benzoic acid, 2-chloro-6-methyl-, 2-[4-methyl-3-[2-(3-quinolinyl)ethynyl]benzoyl]hydrazide
- 中文名:
- K0706
- 中文别名:
- K0706;化合物VODOBATINIB;2-氯-6-甲基-N'-(4-甲基-3-(喹啉-3-基乙炔基)苯甲酰基)苯甲酰肼;2-氯-6-甲基-N'-(4-甲基-3-(喹啉-3-基乙炔基)苯甲酰基)苯甲酰肼
- CBNumber:
- CB65832198
- 分子式:
- C27H20ClN3O2
- 分子量:
- 453.92
- MOL File:
- 1388803-90-4.mol
|
|
|
K0706化学性质
-
沸点:
-
748.6±60.0 °C(Predicted)
-
|
-
密度:
-
1.35±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
DMSO : 125 mg/mL (275.38 mM; Need ultrasonic)
-
|
-
酸度系数(pKa):
-
10.09±0.23(Predicted)
-
|
-
形态:
-
Solid
-
|
-
颜色:
-
White to off-white
-
|
K0706性质、用途与生产工艺
Vodobatinib (K0706) 是一种有效的第三代口服活性 Bcr-Abl1 酪氨酸激酶抑制剂,IC50 为 7 nM。
K0706
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/04/30 | HY-137460 | K0706 Vodobatinib | 1388803-90-4 | 5mg | 900元 |
2024/04/30 | HY-137460 | K0706 Vodobatinib | 1388803-90-4 | 10mM * 1mLin DMSO | 990元 |
1388803-90-4, K0706 相关搜索:
- 天然产物
- 2-氯-6-甲基-N'-(4-甲基-3-(喹啉-3-基乙炔基)苯甲酰基)苯甲酰肼
- 2-氯-6-甲基-N'-(4-甲基-3-(喹啉-3-基乙炔基)苯甲酰基)苯甲酰肼
- 化合物VODOBATINIB
- K0706
- 1388803-90-4
- 2-Chloro-6-methyl-N'-(4-methyl-3-(quinolin-3-ylethynyl)benzoyl)benzohydrazide
- myeloid,Inhibitor,inhibit,Vodobatinib,chronic,K0706,Bcr-Abl,K 0706,Bcr-Abl1,leukemia,TKI
- Vodobatinib (K0706)
- Vodobatinib (SCO-088, SUN-K706
- Vodobatinib
- N'-(2-chloro-6-methylbenzoyl)-4-methyl-3-[2-(3-quinolyl)ethynyl]-benzohydrazide
- Benzoic acid, 2-chloro-6-methyl-, 2-[4-methyl-3-[2-(3-quinolinyl)ethynyl]benzoyl]hydrazide
- 2-Chloro-6-methyl-N'-(4-methyl-3-(quinolin-3-ylethynyl)benzoyl)benzohydrazide